138 related articles for article (PubMed ID: 30840165)
1. What does risk of future cancer mean to breast cancer patients?
Kaiser K; Cameron KA; Beaumont J; Garcia SF; Lacson L; Moran M; Karavites L; Rodgers C; Kulkarni S; Hansen NM; Khan SA
Breast Cancer Res Treat; 2019 Jun; 175(3):579-584. PubMed ID: 30840165
[TBL] [Abstract][Full Text] [Related]
2. Perceptions of Contralateral Breast Cancer Risk: A Prospective, Longitudinal Study.
Portschy PR; Abbott AM; Burke EE; Nzara R; Marmor S; Kuntz KM; Tuttle TM
Ann Surg Oncol; 2015 Nov; 22(12):3846-52. PubMed ID: 25762480
[TBL] [Abstract][Full Text] [Related]
3. Perceptions of contralateral breast cancer: an overestimation of risk.
Abbott A; Rueth N; Pappas-Varco S; Kuntz K; Kerr E; Tuttle T
Ann Surg Oncol; 2011 Oct; 18(11):3129-36. PubMed ID: 21947590
[TBL] [Abstract][Full Text] [Related]
4. Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancer.
Hamilton JG; Genoff MC; Salerno M; Amoroso K; Boyar SR; Sheehan M; Fleischut MH; Siegel B; Arnold AG; Salo-Mullen EE; Hay JL; Offit K; Robson ME
Breast Cancer Res Treat; 2017 Apr; 162(2):297-306. PubMed ID: 28150129
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer treatment in mutation carriers: surgical treatment.
Biglia N; D'Alonzo M; Sgro LG; Tomasi Cont N; Bounous V; Robba E
Minerva Ginecol; 2016 Oct; 68(5):548-56. PubMed ID: 26822896
[TBL] [Abstract][Full Text] [Related]
6. Redefining Risk and Benefit: Understanding the Decision to Undergo Contralateral Prophylactic Mastectomy.
Rendle KA; Halley MC; May SG; Frosch DL
Qual Health Res; 2015 Sep; 25(9):1251-9. PubMed ID: 25371380
[TBL] [Abstract][Full Text] [Related]
7. An informed decision? Breast cancer patients and their knowledge about treatment.
Fagerlin A; Lakhani I; Lantz PM; Janz NK; Morrow M; Schwartz K; Deapen D; Salem B; Liu L; Katz SJ
Patient Educ Couns; 2006 Dec; 64(1-3):303-12. PubMed ID: 16860523
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing surgical treatment decisions for breast cancer: a qualitative exploration of surgeon and patient perspectives.
Dicks E; Roome R; Chafe J; Powell E; McCrate F; Simmonds C; Etchegary H
Curr Oncol; 2019 Apr; 26(2):e216-e225. PubMed ID: 31043830
[TBL] [Abstract][Full Text] [Related]
9. Development and pilot testing of a Decision Aid (DA) for women with early-stage breast cancer considering contralateral prophylactic mastectomy.
Ager B; Jansen J; Porter D; Phillips KA; Glassey R; ; Butow P
Breast; 2018 Aug; 40():156-164. PubMed ID: 29857282
[TBL] [Abstract][Full Text] [Related]
10. Women's preferences for contralateral prophylactic mastectomy following unilateral breast cancer: What risk-reduction makes it worthwhile?
Tesson S; Richards I; Porter D; Phillips KA; Rankin N; Costa D; Musiello T; Marven M; Butow P
Breast; 2017 Feb; 31():233-240. PubMed ID: 27969575
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic mastectomy for the prevention of breast cancer.
Lostumbo L; Carbine N; Wallace J; Ezzo J
Cochrane Database Syst Rev; 2004 Oct; (4):CD002748. PubMed ID: 15495033
[TBL] [Abstract][Full Text] [Related]
12. Contralateral prophylactic mastectomy: A qualitative approach to exploring the decision making process.
Greener JR; Bass SB; Lepore SJ
J Psychosoc Oncol; 2018; 36(2):145-158. PubMed ID: 29064771
[TBL] [Abstract][Full Text] [Related]
13. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
[TBL] [Abstract][Full Text] [Related]
14. Active Participation in Decision-Making in Contralateral Prophylactic Mastectomy for Patients With Breast Cancer.
Huang J; Chagpar A
J Surg Res; 2019 Oct; 242():129-135. PubMed ID: 31075657
[TBL] [Abstract][Full Text] [Related]
15. Physician Knowledge of Breast Cancer Recurrence and Contralateral Breast Cancer Risk is Associated with Increased Recommendations for Contralateral Prophylactic Mastectomy: a Survey of Physicians at NAPBC-Accredited Centers.
Kantor O; Chang C; Bleicher RJ; Moran M; Connolly JL; Kurtzman SH; Yao K;
Ann Surg Oncol; 2019 Oct; 26(10):3080-3088. PubMed ID: 31342369
[TBL] [Abstract][Full Text] [Related]
16. The impact of doctor-patient communication on patients' perceptions of their risk of breast cancer recurrence.
Janz NK; Li Y; Zikmund-Fisher BJ; Jagsi R; Kurian AW; An LC; McLeod MC; Lee KL; Katz SJ; Hawley ST
Breast Cancer Res Treat; 2017 Feb; 161(3):525-535. PubMed ID: 27943007
[TBL] [Abstract][Full Text] [Related]
17. Predicting women's intentions for contralateral prophylactic mastectomy: An application of an extended theory of planned behaviour.
Richards I; Tesson S; Porter D; Phillips KA; Rankin N; Musiello T; Marven M; Butow P
Eur J Oncol Nurs; 2016 Apr; 21():57-65. PubMed ID: 26952679
[TBL] [Abstract][Full Text] [Related]
18. "It felt like unfinished business, it feels like that's finished now": Women's experiences of decision making around contralateral prophylactic mastectomy (CPM).
Tollow P; Williams VS; Harcourt D; Paraskeva N
Psychooncology; 2019 Jun; 28(6):1328-1334. PubMed ID: 30963646
[TBL] [Abstract][Full Text] [Related]
19. Understanding the impact of breast reconstruction on the surgical decision-making process for breast cancer.
Alderman AK; Hawley ST; Waljee J; Mujahid M; Morrow M; Katz SJ
Cancer; 2008 Feb; 112(3):489-94. PubMed ID: 18157830
[TBL] [Abstract][Full Text] [Related]
20. Women's Educational Needs and Perceptions About Survivorship Following Bilateral Mastectomy.
Suplee PD; Jerome-D'Emilia B; Boiler JL
Clin J Oncol Nurs; 2016 Aug; 20(4):411-8. PubMed ID: 27441514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
